Related references
Note: Only part of the references are listed.Human Intestinal Tissue and Cultured Colonic Cells Contain Globotriaosylceramide Synthase mRNA and the Alternate Shiga Toxin Receptor Globotetraosylceramide
Steven D. Zumbrun et al.
INFECTION AND IMMUNITY (2010)
Intracerebroventricular Shiga toxin 2 increases the expression of its receptor globotriaosylceramide and causes dendritic abnormalities
Carla Tironi-Farinati et al.
JOURNAL OF NEUROIMMUNOLOGY (2010)
Therapeutic strategies for Shiga toxin-producingEscherichia coliinfections
Trisha J Rogers et al.
Expert Review of Anti-Infective Therapy (2009)
Development of an experimental hemolytic uremic syndrome in rats
Elsa Zotta et al.
PEDIATRIC NEPHROLOGY (2008)
Inhibition of water absorption in human proximal tubular epithelial cells in response to Shiga toxin-2
Claudia Silberstein et al.
PEDIATRIC NEPHROLOGY (2008)
A nasal vaccine comprising B-subunit derivative of Shiga toxin 2 for cross-protection against Shiga toxin types 1 and 2
Takao Tsuji et al.
VACCINE (2008)
Monovalent Gb3-/Gb2-derivatives conjugated with a phosphatidyl residue:: A novel class of Shiga toxin-neutralizing agent
Paola Neri et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2007)
Intracerebroventricular administration of Shiga toxin type 2 induces striatal neuronal death and glial alterations: An ultrastructural study
Jorge Goldstein et al.
BRAIN RESEARCH (2007)
A specific and potent inhibitor of glucosylceramide synthase for substrate inhibition therapy of Gaucher disease
Kerry Anne McEachern et al.
MOLECULAR GENETICS AND METABOLISM (2007)
Inhibiting glycosphingolipid synthesis improves glycemic control and insulin sensitivity in animal models of type 2 diabetes
Hongmei Zhao et al.
DIABETES (2007)
Targeted disruption of Gb3/CD77 synthase gene resulted in the complete deletion of globo-series glycosphingolipids and loss of sensitivity to vVerotoxins
T Okuda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Cytotoxic effect of Shiga toxin-2 holotoxin and its B subunit on human renal tubular epithelial cells
VP Creydt et al.
MICROBES AND INFECTION (2006)
Long-term course and mechanisms of progression of renal disease in hemolytic uremic syndrome
HA Repetto
KIDNEY INTERNATIONAL (2005)
Interaction of Shiga toxin from Escherichia coli with human intestinal epithelial cell lines and explants:: Stx2 induces epithelial damage in organ culture
S Schüller et al.
CELLULAR MICROBIOLOGY (2004)
Inhibition of glycolipid biosynthesis by N-(5-adamantane-1-yl-methoxy-pentyl)-deoxynojirimycin protects against the inflammatory response in hapten-induced colitis
C Shen et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2004)
The Shiga toxin 2 B subunit inhibits net fluid absorption in human colon and elicits fluid accumulation in rat colon loops
VP Creydt et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2004)
Effect of an oral Shiga toxin-binding agent on diarrhea-associated hemolytic uremic syndrome in children - A randomized controlled trial
H Trachtman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Development of DNA vaccines against hemolytic-uremic syndrome in a murine model
AVE Capozzo et al.
INFECTION AND IMMUNITY (2003)
Protection against Shiga toxin 1 challenge by immunization of mice with purified mutant Shiga toxin 1
S Ishikawa et al.
INFECTION AND IMMUNITY (2003)
Differential tissue targeting and pathogenesis of verotoxins 1 and 2 in the mouse animal model
NWP Rutjes et al.
KIDNEY INTERNATIONAL (2002)
Combinatorial ganglioside biosynthesis.
T Kolter et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Pathogenesis of Shiga toxin-induced hemolytic uremic syndrome
PE Ray et al.
PEDIATRIC NEPHROLOGY (2001)
Efficacy of postinfection treatment with anti-Shiga toxin (Stx) 2 humanized monoclonal antibody TMA-15 in mice lethally challenged with Stx-producing Escherichia coli
S Yamagami et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Oral administration of formaldehyde-killed recombinant bacteria expressing a mimic of the shiga toxin receptor protects mice from fatal challenge with shiga-toxigenic Escherichia coli
JC Paton et al.
INFECTION AND IMMUNITY (2001)
Apoptosis of renal tubular cells in shiga-toxin-mediated hemolytic uremic syndrome
K Kaneko et al.
NEPHRON (2001)
Reduction of globotriaosylceramide in Fabry disease mice by substrate deprivation
A Abe et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Share Paper
